Article Text

PDF

Epithelial-fibroblast interactions in pulmonary fibrosis
S70 Mesenchymal Stem Cell Conditioned Media (MSC-CM) Suppress Wnt-3A and TGF-β1-Induced Myofibroblastic Differentiation
  1. S Samad,
  2. KM Akram,
  3. NR Forsyth,
  4. M Spiteri
  1. Guy Hilton Research Centre, Stoke on trent, United Kingdom

Abstract

Hypothesis Idiopathic pulmonary fibrosis (IPF) remains an incurable fibrotic lung disease. A mesenchymal stem cell (MSC)-mediated regenerative approach has been proposed; MSC-mediated anti-fibrotic effects have been demonstrated in animal lung-fibrosis models. However the mechanism of action and effect on myofibroblastic differentiation are unknown. The Wnt family member, Wnt-3a, has been implicated as an inducer of myofibroblastic differentiation in fibroblast cell models. This study explores the influence of MSC secreted factors on Wnt-3a and TGF-β1-induced lung myofibroblastic differentiation.

Method Human normal lung (CCD-8Lu) and IPF (LL29) fibroblasts were differentiated with Wnt-3a for 72-hours and TGF-β1 for 24-hours. MSC-mediated differentiation inhibition was assessed by co-incubation of fibroblasts with MSC-CM and either Wnt-3a for 72-hours or TGF-β1 for 24-hours. TGF-β1-induced myofibroblastic differentiation reversal was explored with MSC-CM incubation for 24, 48 and 72-hours. Myofibroblast differentiation was assessed by immunocytochemical detection of α-smooth muscle actin expression.

Results Myofibroblastic differentiation following TGF-β1 treatment was achieved in 86.27+2.57% CCD-8Lu cells and 86.69+2.51% LL29 cells respectively. Similar, though reduced, levels of myofibroblastic differentiation were achieved in 52.9±0.2% CCD-8Lu and 55.6±5.9% LL29 cells respectively following Wnt-3a treatment.

In contrast, a percentage reduction in myofibroblastic differentiation was achieved in CCD-8Lu 31.40+1.44% and LL29 35.69+7.47% cells following exposure to TGF-β1 in the presence of MSC-CM versus TGF-β1 alone (p<0.001). Similarly, we observed a striking percentage reduction in myofibroblastic differentiation following co-incubation with Wnt-3a and MSC-CM versus Wnt-3a alone (p<0.001); 80.76±3.64% of CCD-8Lu and 79.67±3.94% of LL29 cells.

A reversal of TGF-β1-induced myofibroblastic differentiation was observed following 72-hours administration of MSC-CM compared to serum-free culture media (p<0.001). Interestingly, we observed a MSC-CM exposure duration effect on the total myofibroblast percentage present in both CCD8-Lu and LL29 cells; 81.7+0.43% and 73.26+0.70% respectively at 24-hours, 72.15+0.81% and 60.57+4.27% at 48-hours, 57.63+4.54% and 60.65+4.9% at 72-hours.

Conclusion MSC-CM appears to inhibit fibroblast to myofibroblast differentiation, over-riding the pro-differentiation effects of Wnt-3a and TGF-β1. Whilst both TGF-β1 and Wnt-3a have emerged as key players in IPF pathogenesis, we are the first to demonstrate that MSC-CM may be crucial in modulating their pro-fibrogenic effects. These actions of MSC-CM demonstrate exploitative potential for future anti-IPF therapeutic strategies.

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.